EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-level Computational Screening of Withanolides from Physalis philadelphica for Renal Adenocarcinoma Therapeutics

Hung Duc Nguyen

Biointerface Research in Applied Chemistry · 15.06.2026 · 16 (3)

DOI: 10.33263/briac163.080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biointerface Research in Applied Chemistry, online erschienen am 15.06.2026. Verfasst von Hung Duc Nguyen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma, particularly advanced clear-cell disease, continues to require new mechanism-guided therapeutic options. Withanolides from Physalis philadelphica represent a structurally diverse natural-product class with reported cytotoxicity, but target-level mechanisms remain insufficiently defined. The present study performed a multi-level in silico evaluation of selected withanolides from Physalis philadelphica against the anti-apoptotic protein Mcl-1 (PDB: 6QFQ), using Belzutifan as a comparative reference. Docking analysis identified withaphysacarpin (CPD2) as the top-ranked candidate, with a predicted affinity more favorable than that of Belzutifan and a BH3-groove contact pattern dominated by hydrophobic and van der Waals interactions. Subsequent 100 ns molecular dynamics simulations supported the dynamic stability of the CPD2-6QFQ and Belzutifan-6QFQ complexes, with preserved backbone stability, compactness, and limited local fluctuations. MMGBSA analysis further favored CPD2 over Belzutifan, with a more favorable predicted binding profile driven mainly by nonpolar packing and a lower solvation penalty. ADMET prediction suggested a mixed developability profile for CPD2, including a comparatively favorable CYP inhibition pattern alongside an AMES mutagenicity alert. Current findings support CPD2 as a computationally prioritized candidate scaffold for Mcl-1-directed RCC research, while emphasizing the need for biochemical target validation, cellular apoptosis assays, selectivity profiling, and confirmatory safety testing.

Zitieren

APA

Nguyen, H. D. (2026). Multi-level Computational Screening of Withanolides from Physalis philadelphica for Renal Adenocarcinoma Therapeutics. Biointerface Research in Applied Chemistry, 16(3). https://doi.org/10.33263/briac163.080

Vancouver

Nguyen HD. Multi-level Computational Screening of Withanolides from Physalis philadelphica for Renal Adenocarcinoma Therapeutics. Biointerface Research in Applied Chemistry. 2026;16(3). doi:10.33263/briac163.080

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Hung Duc},
  title = {Multi-level Computational Screening of Withanolides from Physalis philadelphica for Renal Adenocarcinoma Therapeutics},
  journal = {Biointerface Research in Applied Chemistry},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.33263/briac163.080}
}
Kostenlos starten →